drugset / Trial / NCT02146625
Safety, Tolerability, PK, PD, ADA of Escalating Single Dose of CJ-40002 in Healthy Male Subjects
RandomizedParallel-groupSingle-blindBasic science
Summary
The objectives of this study are: * To evaluate the safety and tolerability of CJ-40002 after single SC injection in healthy male volunteers. * To evaluate the PK of CJ-40002 after single SC injection in healthy male volunteers. * To evaluate the PD of CJ-40002 after single SC injection in healthy male volunteers. * To evaluate the ADA of CJ-40002 after single SC injection in healthy male volunteers.
Timeline
- Start
- 2014-11
- Primary completion
- 2015-03
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CJ-40002 | Unknown | — | Subcutaneous |
Indications
No indication recorded.